Acupotomy Therapy for Chronic Nonspecific Neck Pain: A Systematic Review and Meta-Analysis.

Acupotomy Therapy for Chronic Nonspecific Neck Pain: A Systematic Review and Meta-Analysis.
复制标题

DOI:
10.1155/2017/6197308
复制
发表时间:
2017
期刊:
Evidence-based complementary and alternative medicine : eCAM
影响因子:
--
通讯作者:
Yan X
Yan X
中科院分区:
其他
文献类型:
--
作者:
Liu F;Zhou F;Zhao M;Fang T;Chen M;Yan X

文献摘要

参考文献

被引文献

相似文献

本综述旨在评估针刀疗法治疗慢性非特异性颈部疼痛的有效性和安全性。我们检索了六个计算机化数据库。纳入了单独针刀疗法或与其他常规疗法相结合治疗慢性非特异性颈部疼痛的随机对照试验。两名评审员根据 Cochrane 综述手册(5.1)独立筛选每篇文献并提取数据。应用 Cochrane Collaboration 的 RevMan 5.3 软件进行荟萃分析。 总共纳入了 10 项试验,涉及 433 名患者。汇总分析表明,针刀疗法在有效率和治愈率方面显示出显着改善的短期和长期效果。 Meta分析表明,针刀治疗组在恢复颈椎前凸和降低VAS评分方面优于对照组。连续数据的结果并不支持针刀治疗在调整临床症状评分方面具有统计学意义。对于不良事件,针刀组与对照组相比没有表现出明显的优越性。 针刀疗法可能对慢性非特异性颈部疼痛患者有益。为了加强支持性证据,建议未来进行更严格设计的临床试验、充分的不良事件和后续项目。
This review is to assess the efficacy and safety of acupotomy therapy in chronic nonspecific neck pain. We searched six computerised databases. Randomized controlled trials incorporating acupotomy therapy alone or combined with other conventional treatments for chronic nonspecific neck pain were included. Two reviewers screened each literature and extracted data independently according to Cochrane Reviews' Handbook (5.1). The Cochrane Collaboration's RevMan 5.3 software was applied for meta-analysis. A total of ten trials involving 433 patients were enrolled. The pooled analysis indicated that acupotomy therapy showed a significant improving short-term and long-term effect on effective rate and cure rate. Meta-analysis demonstrated that acupotomy therapy group was superior to control group in restoring cervical lordosis and debasing VAS score. The result of continuous data did not support statistical significance of acupotomy therapy in adjusting clinical symptom score. For adverse events, acupotomy group did not reveal obvious superiority compared to control group. Acupotomy therapy may be beneficial to chronic nonspecific neck pain patients. To strengthen supportive evidence, future, more rigorously designed clinical trials, adequate adverse events, and follow-up project are recommended.
DOI: 10.1016/s0254-6272(14)60078-9
发表时间: 2014-04-15
影响因子: 2.6
作者:
Guo, Changqing;Liu, Naigang;Wu, Haixia
通讯作者: Wu, Haixia
DOI: 10.1016/j.jams.2015.09.001
发表时间: 2016-02-01
影响因子: 1
作者:
Kim, Hyun-ji;Jeon, Ju-hyun;Kim, Young-il
通讯作者: Kim, Young-il
DOI: 10.3233/bmr-150339
发表时间: 2017-01-01
影响因子: 1.6
作者:
Meziat-Filho, Ney;Azevedo e Silva, Gulnar;Santos, Vivian
通讯作者: Santos, Vivian
DOI: 10.1016/j.berh.2011.01.019
发表时间: 2010-12-01
影响因子: 5.2
作者:
Hoy, D. G.;Protani, M.;Buchbinder, R.
通讯作者: Buchbinder, R.
DOI: 10.1136/acupmed-2013-010410
发表时间: 2014-02-01
影响因子: 2.5
作者:
Cho, Jae-Heung;Nam, Dong-Hyun;Lee, Jun-Hwan
通讯作者: Lee, Jun-Hwan